Pathogenesis of infections induced by Candida albicans;Patogeneza zakażeń wywołanych przez Candida albicans

Mikologia Lekarska

Volumn 9, Issue 3, 2002, Pages 137-143

  Nawrot, Urszula ^a   Karpiewska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Candida albicans; Pathogenesis of candidosis

Indexed keywords

GENE PRODUCT; GLIOTOXIN; HYDROLASE; PHOSPHOLIPASE; PROTEINASE; VIRULENCE FACTOR;

CANDIDA ALBICANS; CANDIDIASIS; ENDOTHELIUM; ENZYME RELEASE; EPITHELIUM; GENE DELETION; GENE FUNCTION; HEMOLYSIS; NONHUMAN; PATHOGENESIS; REVIEW; VIRULENCE;

EID: 0036441551     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Richardson M.D., Warnock D.W.: Grzybice. Rozpoznawanie i Leczenie. Springer PWN, Warszawa, 1995, 77-92.
2. Macura A.B.: Patomechanizm zakażeń grzybiczych. Rozdz. 7 [w:] Zarys Mikologil Lekarskiej. red. E. Baran, Volumed, Wrocław, 1998, 297-309.
3. Pincus D.H., Coleman D.C., Pruitt W.R., Padhye A.A., Salkin I.F., Geimer M., Bassel A., Sullivan D.J., Clarke M., Heardn V.: Rapid identification of Candida dubliniensis with commercial yeast identification systems. J. Clin. Microbiol., 1999, 37, 3533-3539.
4. Chaffin W.L., Lopez-Ribot J.L., Casanova M., Gozalbo D., Martinez J.P.: Cell wall and secreted proteins of Candida albicans: Identification, function and expression. Microbiol. Mol. Biol. Rev., 1998, 62, 130-180.
5. Klis F.M.: Review: Cell wall assembly in yeast. Yeast, 1994, 10, 851-869.
6. Ruiz-Herrera J., Mormeneo S., Vanaclocha P., Font de Mora J., Iranzo M., Puertes I., Sentandreu R.: Structural organization of the components of the cell wall from Candida albicans. Microbiology, 1994, 140, 1513-1523.
7. Diez-Orejas R., Molero G., Rios-Serrano I., Vazquez A., Gil C., Nombela C., Sanchez-Perez M.: Low virulence of a morphological Candida albicans mutant. FEMS Microbiol. Lett., 1999, 176, 311-319.
8. Lo H.J., Kohler J.R., DiDomenico B., Loenbenberg D., Cacciapuoti A., Fink G.R.: Nonfilamentous Candida albicans mutants are avirulent. Cell, 1997, 90, 939-949.
9. Mitchell A.P.: Dimorphism and virulence in Candida albicans. Curr. Opin. Microbiol., 1998, 1, 687-692.
10. Liu H.: Transcriptional control of dimorphism in Candida albicans. Curr. Opin. Microbiol., 2001, 4, 728-735.
11. Calderone R.A., Fonzi W.A.: Virulence factors of Candida albicans. Trends Microbiol., 2001, 7, 327-335.
12. Staab J.F., Ferrer C.A., Sundstrom P.: Developmental expression of a tandemly repeated, proline- and glutamine-rich amino acid motif on hyphal surfaces on Candida albicans. J. Biol. Chem., 1996, 271, 6298-6305.
13. Sharkey L.L., McNemar M.D., Saporito-Irwin S.M., Sypherd P.S., Fonzi W.A.: HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. J. Bacteriol, 1999, 181, 5273-5279.
14. Saporito-Irwin M.Y., Brise C.E., Sypherd P.S., Fonzi W.A.: PHR1, a ph-regulated gene of Candida albicans is required for morphogenesis. Mol. Cell Biol., 1995, 15, 601-613.
15. Davis D., Wilson R.B., Mitchell A.P.: RIM 101-dependent and independent pathways govern pH responses in Candida albicans. Mol. Cell. Biol., 2000, 20, 971-978.
16. Sentandreu M., Elorza M.V., Sentandreu R., Fonzi W.A.: Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans, J. Bactedol., 1998, 180, 282-289.
17. Gow N.A., Robbins P.W., Lester J.W., Brown A.J., Fonzi W.A., Chapman T., Kinsman O.S.: A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc. Natl. Acad. Sci USA, 1994, 91, 6216-6220.
18. Chen-Wu J.L., Zwicker J., Bowen A.R., Robbins P.W.: Expression of chitin synthase genes during yeast and hyphal growth phases of Candida albicans. Mol. Microbiol., 1992, 6, 497-502.
19. Mio T., Yabe T., Sudoh M., Satoh Y., Nakajima T., Adsawa M., Yamada-Okabe H.: Role of three chitin synthase genes in the growth of Candida albicans. J. Bacteriol. 1996, 178, 2416-2419.
20. Birse C.E., Irwin M.Y., Fonzi W.A., Sypherd P.S.: Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect. Immun., 1993, 61, 3648-3655.
21. Braun B.R., Johnson A.D.: TUP1, CPH1, and EFG1 make independent contribution to filamentation in Candida albicans. Genetics, 2000, 155, 57-67.
22. Braun B.R., Johnson A.D.: Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science, 1997, 277, 105-109.
23. Braun B.R., Head W.S., Wang M.X., Johnson A.D.: Identification and characterisation of TUP-1 regulated genes in C. albicans. Genetics, 2000, 156, 31-44.
24. Stoldt V.R., Sonnebom A., Leuker C.E., Emst J.F.: Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J., 1997, 16, 1982-1991.
25. Bahn Y.S. Sundstrom P.: CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans. J. Bacteriol., 2001, 183, 3211-3223.
26. Krajewska-Kułak E., Łukaszuk C., Niczypurok W., Bartoszewicz M., Roszkowska I., Szczurzewski M., Trybuta J.: Biotypy enzymatyczne szczepów grzybów drożdżopodobnych izolowanych z różnych ontocenoz. Mikol. Lek., 2001, 8, 13-17.
27. Kumatowska A.J., Kumatowski P.: Biotypes of fungi isolated from patients with oral cavity diseases. Mikol. Lek., 1998, 5, 213-217.
28. Shimizu M.T., Almeida N.Q., Fantinato V., Unterkircher C.S.: Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses, 1996, 39, 161-167.
29. Hube B.: Extracellular proteinases of human pathogenic fungi. [w:] Dimorphism in Human Pathogenic and Apathogenic Yeasts. red. Ernst J.F., Schmidt A. Contrib. Microbiol. Basel. Karger, 2000, 5, 126-137.
30. White T.C., Agabian N.: Candida albicans secreted aspartyl proteinases: Isoenzyme pattern is determinated by cell type and levels are determinated by enviromental factors. J. Bacteriol., 1995, 177, 5215-5221.
31. Wagner T., Borg von Zepelin M., Ruchel R.: pH dependent denaturation of extracellular aspartic proteinases from Candida species. J. Med. Vet. Mycol., 1995, 33, 275-278.
32. Kaminishi H., Tanaka M., Cho T., Maeda H., Hagihara Y.: Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect. Immun., 1990, 58, 2139-2143.
33. Kaminishi H., Miyaguchi H., Tamaki T., Suenaga N., Hisamatsu M., Mihashi I., Matsumoto H., Maeda H., Hagihara Y.: Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun., 1995, 63, 984-988.
34. El-Maghrabi E.A. Dixon D.M., Burnett J.W.: Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherence to keratinocytes. Clin. Exp. Dermat., 1990, 15, 183-191.
35. Ollert M.W., Sohnchen R., Korting H.C., Ollert U., Brautigam S., Brautigam W.: Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun., 1993, 61, 4560-4568.
36. Ripeau J.S., Fiorillo M., Aumont F., Belhumeur P., de Repentigny L.: Evidence for differential expression of Candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice. J. Infect. Dis., 2002, 185, 1094-1102.
37. Shaller M., Korting H.C., Schafer W., Basterd J., Chen W., Hube B.: Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol., 1999, 34, 169-180.
38. De Bernardis F., Arancia S., Morelli L., Hube B., Sanglard D., Schafer W., Cassone A.: Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2 are virulence factors for Candida vaginitis. J. Infect. Dis., 1999, 179, 201-208.
39. Felk A., Kretschmar M., Albrecht A., Schaller M., Beinhauer S., Nichterlein T., Sanglard D., Korting H.C., Schafer W., Hube B.: Candida albicans hyphal formation and expression of Efg1-regulated proteinases SAP4 to SAP6 are required for the invasion of parenchymal organs. Infect. Immun., 2002, 70, 3689-700.
40. Pranav-Kumar S.K., Kulkurni V.M.: Insights into the selective inhibition of Candida albicans aspartyl protease: A docking analysis study. Bioorg. Med. Chem., 2002, 10, 1153-1170.
41. Cassone A., Tacconelli E., De Bernardis F., Tumbarello M., Torosantucci A., Chiani P., Cauda R.: Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J. Infect. Dis., 2002, 185, 188-195.
42. Ghannoum M.A.: Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev., 2000, 13, 122-143.
43. Ibrahim A.S., Mirbod F., Filler S.C., Banno Y., Cole G.T., Kitajima Y., Edwards J.E., Nozawa Y., Ghannoum M.A.: Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun., 1995, 63, 1993-1998.
44. Mirbod F., Banno Y., Ghannoum M.A., Ibrahim A.S., Nakashima S., Kitajima Y., Cole G.T., Nozawa Y.: Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim. Biophys. Acta, 1995, 1257, 181-188.
45. Leidich, S.D., Ibrahim A.S., Fu Y., Koul A., Jessup C., Vitullo J., Fonzi W., Mirbod F., Nakashima S., Nozawa Y., Ghannoum M.A.: Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem., 1998, 273, 26078-26086.
46. Barrett-Bee, K., Hayes Y., Wilson R.G., Ryley J.F.: A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J. Gen. Microbiol. 1985, 131, 1217-1221.
47. Mukherjee P.K., Seshan K.R., Leidich S.D., Chandra J., Cole G.T., Ghannoum M.A.: Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. Microbiology, 2001, 147, 2585-2597.
48. Falo L.D., Haber S. I., Hermann S., Benacerraf B., Rock K.J.: Characterization of antigen association with accessory cells: Specfic removal of processed antigens from the cell surface by phospholipeses. Proc. Natl. Acad. Sci. USA, 1987, 84, 522-526.
49. Bennett D.E., McCreary C.E., Coleman D.C.: Genetic characterization of a phospholipase C gene from Candida albicans: Presence of homologous sequences in Candida species other than Candida albicans. Microbiology, 1998, 144, 55-72.
50. McLain N., Dolan J.W.: Phospholipase D activity is required for dimorphic transition in Candida albicans. Microbiology, 1997, 143, 3521-3526.
51. Hube B., Hess D., Baker C.A., Schaller M., Schafer W., Dolan J.W.: The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology, 2001, 147, 879-889.
52. Hostetter M.K.: Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev., 1994, 7, 29-42.
53. Pendrak M.L., Klotz S.A.: Adherence of Candida albicans to host cells. FEMS Microbiol. Lett., 1995, 129, 103-114.
54. Calderone R., Wadsworth E.: Adherence molecules of Candida albicans. J. Microbiol. Methods, 1993, 18, 197-211.
55. Forsyth C.B., Mathews H.L.: Lymphocyte adhesion to Candida albicans. Infect. Immun., 2002, 70, 517-527.
56. Bemhardt J., Herman D., Sheridan M., Calderone R.: Adherence and invasion studies of Candida albicans strains, using in vitro models of esophageal candidiasis. J. Infect. Dis., 2001, 184, 1170-1175.
57. Filler S.G., Swerdloff J.N., Hobbs C., Luckett P.M.: Penetration and damage of endotelial cells by Candida albicans. Infect. Immun., 1995, 63, 976-983.
58. Macura-Biegun A., Macura A.B.: Interakcje grzybów Candida albicans z białkami macierzy zewna̧trzkomórkowej - Ich udział w powstawaniu kandydozy. Mikol. Lek., 1997, 4, 221-225.
59. Santoni G., Gismondi A., Liu J.H., Punturieri A., Santoni A., Frati L., Piccoli M., Djeu J.Y.: Candida albicans expresses a fibronectin receptor antigenically related to αδβ1 integrin. Microbiology, 1994, 140, 2971-2979.
60. Bouchara J.P., Tronchin G., Annaix V., Robert R., Senet J.M.: Laminin receptors on Candida albicans germ tubes. Infect. Immun., 1990, 58, 48-54.
61. Calderone R.A., Linehan L., Wadsworth E., Sandberg A.L.: Identification of C3d receptors on Candida albicans. Infect. Immun., 1988, 56, 252-258.
62. Gilmore B.J., Retsinas E.M., Lorenz S.J., Hostetter M.K.: An iC3b receptor on Candida albicans: Structure, function and correlates for pathogenicity. J. Infect. Dis., 1988, 157, 38-46.
63. Bouali A.R., Robert R., Tronchin G., Senet J.M.: Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of Candida albicans. J. Gen. Microbiol., 1987, 133, 545-551.
64. Hawser S.P., Islam K.: Binding of Candida albicans to immobilized amino acids and bovine serum albumin. Infect. Immun., 1998, 66, 140-144.
65. Millsap K.W., Van der Mei H.C., Bos R., Busscher H.J.: Adhesive interactions between medically important yeasts and bacteria. FEMS Microbiol. Rev., 1998, 21, 321-336.
66. Tronchin G., Bouchara J.P., Robert R., Senet J.M.: Adherence of Candida albicans germ tubes to plastic: Ultrastructural and molecular studies of fibrillar adhesins. Infect. Immun., 1988, 56, 1987-1993.
67. Tosh F.D., Douglas L.J.: Characterization of a fucoside-binding adhesin of Candida albicans. Infect. Immun., 1992, 60, 4734-4739.
68. Cameron B.J., Douglas L.J.: Blood group glycolipids as epithelial cell receptors for Candida albicans. Infect. Immun., 1996, 64, 891-896.
69. Wurzner R., Gruber A., Stoiber H., Spruth M., Chen Y.H., Lukasser-Vogl E., Schwendinger M.G., Dierich M.P.: Human immunodeficiency virus type 1 gp41 binds to Candida albicans via complement C3-like regions. J. Infect. Dis., 1997, 176, 492-498.
70. Fu Y., Ibrahim A.S., Sheppard D.C., Chen Y.C., French S.W., Cutler J.E., Filler S.G., Edwards J. E.: Candida albicans Als1p: An adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol. Microbiol., 2002, 44, 61-72.
71. Gaur N.K., Klotz S.A.: Expression, cloning, and characterization of a Candida albicans gene ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect Immun., 1997, 65, 5289-5294.
72. Sundstrom P., Cutler J.E., Staab J.F.: Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect. Immun., 2002, 70, 3281-3283.
73. Gale C.A., Bendel C.M., McClellan M., Hauser M., Becker J.M., Berman J., Hostetter M.K.: Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science, 1998, 279, 1355-1358.
74. Buurman E.T., Westwater C., Hube B., Brown A.J., Odds F.C., Gow N.A.: Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans. Proc. Natl. Acad. Sci USA, 1998, 95, 7670-7675.
75. Drago L., Mombelli B., DeVecchi E., Bonnacorso C., Fassina M. C., Gismondo M.R.: Candida albicans cellular internalization: A new pathogenic factor? Int. J. Antimicrob. Agents, 2000, 16, 545-547.
76. Watanabe T., Takano M., Murakami M., Tanaka H., Matsuhisa A., Nakao N., Mikami T., Suzuki M., Matsumoto T.: Characterization of a haemolytic factor from Candida albicans. Microbiology, 1999, 145, 689-694.
77. Shah D.T., Larsen B.: Clinical isolates of yeast produce a gliotoxin-like substance. Mycopathologia, 1991, 116, 203-208.
78. Shah D.T., Glover D.D., Larsen B.: In situ mycotoxin production by Candida albicans in women with vaginitis. Gynecol. Obstet. Invest., 1995, 39, 67-69.
79. Shah D.T., Jackman S., Engle J., Larsen B.: Effect of gliotoxin on human polymorphonuclear neutrophils. Infect. Dis. Obstet. Gynecol., 1998, 6, 168-175.
80. Marodi L.: Local and systemic host defense mechanisms against Candida: immunopathology of candidal infections. Pediatr. Infect. Dis. J., 1997, 16, 795-801.
81. Bromuro C., Torosantucci A., Gomez M.J., Urbani F., Cassone A.: Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans. J. Med. Vet. Mycol., 1994, 32, 447-459.
82. Podzorski R.P., Gray G.R., Nelson R.D.: Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J. Immunol., 1990, 144, 707-716.
83. Polonelli L., Gerloni M., Conti S., Fisicaro P., Cantelli C., Portincasa P., Almondo F., Barea P.L., Hernando F.L., Ponton J.: Heatshock mannoproteins as targets of secretory IgA in Candida albicans. J. Infect. Dis, 1994, 169, 1401-1405.
84. Panaretou B., Sinclair K., Prodromou C., Johal J., Pearl L., Piper P.W.: The Hsp90 of Candida albicans can confer Hsp90 functions in Saccharomyces cerevisiae: A potential model for the processes that generate immunogenic fragments of this molecular chaperone in C. albicans infections. Microbiology, 1999, 145, 3455-3463.
85. Sundstrom P., Jensen J., Balish E.: Humoral and cellular immune responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. J. Infect. Dis., 1994, 170, 390-395.
86. Picconella E., Lombardi G., Morelli R.: Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from C. albicans. J. Immunol., 1981, 126, 2151-2155.
87. Durandy A., Fischer A., Le Deist F., Drouhet E., Griscelli C.: Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J. Clin. Immunol., 1987, 7, 400-409.
88. Witkin S.S., Hirsch J., Ledger W.J.: A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol., 1986, 155, 790-795.
89. Kalo-Klein A., Witkin S.S.: Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect. Immun., 1990, 58, 260-262
90. Noverr M.C., Phare S.M., Toews G.B., Coffey M.J., Huffnagle G.B.: Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun., 2001, 69, 2957-2963.